SteelPeak Wealth LLC Buys 809 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

SteelPeak Wealth LLC raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 125.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,453 shares of the biotechnology company's stock after purchasing an additional 809 shares during the quarter. SteelPeak Wealth LLC's holdings in Axon Enterprise were worth $864,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in AXON. Public Sector Pension Investment Board increased its stake in Axon Enterprise by 79.5% in the 2nd quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company's stock valued at $766,000 after purchasing an additional 1,153 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in Axon Enterprise by 1.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 43,367 shares of the biotechnology company's stock valued at $12,760,000 after acquiring an additional 535 shares in the last quarter. Creative Planning increased its stake in shares of Axon Enterprise by 9.6% during the 2nd quarter. Creative Planning now owns 16,463 shares of the biotechnology company's stock worth $4,844,000 after purchasing an additional 1,441 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its position in Axon Enterprise by 30.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company's stock worth $236,000 after purchasing an additional 188 shares in the last quarter. Finally, EP Wealth Advisors LLC raised its position in shares of Axon Enterprise by 18.3% in the second quarter. EP Wealth Advisors LLC now owns 1,577 shares of the biotechnology company's stock valued at $464,000 after buying an additional 244 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded up $13.46 during trading hours on Thursday, reaching $653.43. The stock had a trading volume of 536,604 shares, compared to its average volume of 565,590. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business's fifty day moving average is $618.90 and its two-hundred day moving average is $477.78. The company has a market cap of $49.82 billion, a price-to-earnings ratio of 168.85, a PEG ratio of 6.09 and a beta of 1.04.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on AXON. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a report on Monday, November 11th. JMP Securities lifted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research note on Thursday, October 31st. Finally, Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $524.85.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 over the last ninety days. 6.10% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.